ATLANTA, July 13, 2018 /PRNewswire-USNewswire/ — In recognition of World Sickle Cell Day, a coalition led by the Sickle Cell Foundation of Georgia, Inc. (SCFG), announced a fund-raising campaign to launch the first clinical trials investigating the efficacy of cannabis oil for pain associated with Sickle Cell Disease. The coalition includes Biotech, Inc. and the Phoenix Tears Foundation.
“We urge the Sickle Cell community, our friends and allies to join in supporting the coalition as we search for alternative treatments for those battling this painful and sometimes fatal condition,” said Deb McGhee McCrary, SCFG President CEO. “These trials will fully explore the pain relief properties of medical cannabis as an alternative to highly addictive opioids.”
The Georgia Legislature made history when Sickle Cell Disease was added to the list of maladies approved for Medical Cannabis opening the door for clinical trials. This is the first clinical trial